Korean Drug Co. Ltd Free Cash Flow Generation Index
Korean Drug Co. Ltd free cash flow generation index. Korean Drug Co. Ltd (014570) has a Free Cash Flow Generation Index of 0.99x as of June 2026. Free cash flow of ₩1.89 Billion represents 1% of operating cash flow (₩1.90 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Korean Drug Co. Ltd (2014–2025)
Free cash flow generation index of Korean Drug Co. Ltd from 2014 to 2025. Historical FCF Generation Index trend for Korean Drug Co. Ltd across 11 annual periods. See 014570 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Korean Drug Co. Ltd Free Cash Flow Generation Index by Year (2014–2025)
Korean Drug Co. Ltd free cash flow generation index by year from 2014 to 2025. Year-by-year Free Cash Flow Generation Index for Korean Drug Co. Ltd. For the full cash flow conversion analysis, see 014570 cash flow conversion.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | ₩12.63 Billion | ₩13.11 Billion | ₩475.05 Million | ▲ +22.6% |
| 2024 | 0.79x | ₩3.83 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +923.3% |
| 2022 | -0.10x | ₩-564.37 Million | ₩5.91 Billion | ₩6.09 Billion | ▼ -111.0% |
| 2021 | 0.87x | ₩7.65 Billion | ₩8.81 Billion | ₩1.15 Billion | ▼ -7.5% |
| 2020 | 0.94x | ₩11.57 Billion | ₩12.33 Billion | ₩738.47 Million | ▼ -37.1% |
| 2019 | 1.49x | ₩9.26 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +21.8% |
| 2018 | 1.22x | ₩7.09 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -65.3% |
| 2017 | 3.53x | ₩1.58 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +216.4% |
| 2016 | 1.12x | ₩4.42 Billion | ₩3.96 Billion | ₩460.84 Million | ▼ -2.4% |
| 2015 | 1.14x | ₩7.01 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +2.0% |
| 2014 | 1.12x | ₩5.00 Billion | ₩4.46 Billion | ₩538.19 Million | — |